Intrafamilial phenotypic heterogeneity in siblings with pseudohypoparathyroidism 1B due to maternal

STX16 GNAS infantile obesity pseudohypoparathyroidism type 1B

Journal

Journal of pediatric endocrinology & metabolism : JPEM
ISSN: 2191-0251
Titre abrégé: J Pediatr Endocrinol Metab
Pays: Germany
ID NLM: 9508900

Informations de publication

Date de publication:
14 Dec 2023
Historique:
received: 31 05 2023
accepted: 15 11 2023
medline: 14 12 2023
pubmed: 14 12 2023
entrez: 14 12 2023
Statut: aheadofprint

Résumé

Pseudohypoparathyroidism (PHP1B) is most commonly caused by epigenetic defects resulting in loss of methylation at the GNAS locus, although deletions of We report three siblings with autosomal dominant PHP1B caused by a deletion in PHP1B from a

Identifiants

pubmed: 38095637
pii: jpem-2023-0249
doi: 10.1515/jpem-2023-0249
doi:

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2023 Walter de Gruyter GmbH, Berlin/Boston.

Références

Wilson, LC. Albright’s hereditary osteodystrophy. J Pediatr Endocrinol Metab 2006;19:671–3. https://doi.org/10.1515/jpem.2006.19.s2.671 .
doi: 10.1515/jpem.2006.19.s2.671
Mantovani, G. Clinical review: pseudohypoparathyroidism: diagnosis and treatment. J Clin Endocrinol Metab 2011;96:3020–30. https://doi.org/10.1210/jc.2011-1048 .
doi: 10.1210/jc.2011-1048
Thiele, S, Mantovani, G, Barlier, A, Boldrin, V, Bordogna, P, De Sanctis, L, et al.. From pseudohypoparathyroidism to inactivating PTH/PTHrP signalling disorder (iPPSD), a novel classification proposed by the EuroPHP network. Eur J Endocrinol 2016;175:1–17. https://doi.org/10.1530/eje-16-0107 .
doi: 10.1530/eje-16-0107
Peters, J, Williamson, CM. Control of imprinting at the Gnas Cluster. Adv Exp Med Biol 2008;626:16–26. https://doi.org/10.1007/978-0-387-77576-0_2 .
doi: 10.1007/978-0-387-77576-0_2
Linglart, A, Gensure, RC, Olney, RC, Jüppner, H, Bastepe, M. A novel STX16 deletion in autosomal dominant pseudohypoparathyroidism type Ib redefines the boundaries of a cis-acting imprinting control element of GNAS. Am J Human Genet 2005;76:804–14. https://doi.org/10.1086/429932 .
doi: 10.1086/429932
Grüters-Kieslich, A, Reyes, M, Sharma, A, Demirci, C, DeClue, TJ, Lankes, E, et al.. Early-onset obesity: unrecognized first evidence for GNAS mutations and methylation changes. J Clin Endocrinol Metab 2017;102:2670–7. https://doi.org/10.1210/jc.2017-00395 .
doi: 10.1210/jc.2017-00395
Kiuchi, Z, Reyes, M, Hanna, P, Sharma, A, DeClue, T, Olney, RC, et al.. Progression of PTH resistance in autosomal dominant pseudohypoparathyroidism type Ib due to maternal STX16 deletions. J Clin Endocrinol Metab 2022;107:E681–7. https://doi.org/10.1210/clinem/dgab660 .
doi: 10.1210/clinem/dgab660
Bastepe, M, Pincus, JE, Sugimoto, T, Tojo, K, Kanatani, M, Azuma, Y, et al.. Positional dissociation between the genetic mutation responsible for pseudohypoparathyroidism type Ib and the associated methylation defect at exon A/B: evidence for a long-range regulatory element within the imprinted GNAS1 locus. Hum Mol Genet 2001;10:1231–41. https://doi.org/10.1093/hmg/10.12.1231 .
doi: 10.1093/hmg/10.12.1231
Bastepe, M. The GNAS locus and pseudohypoparathyroidism. Adv Exp Med Biol 2008;626:27–40. https://doi.org/10.1007/978-0-387-77576-0_3 .
doi: 10.1007/978-0-387-77576-0_3
Bastepe, M, Fröhlich, LF, Hendy, GN, Indridason, OS, Josse, RG, Koshiyama, H, et al.. Autosomal dominant pseudohypoparathyroidism type Ib is associated with a heterozygous microdeletion that likely disrupts a putative imprinting control element of GNAS. J Clin Invest 2003;112:1255–63. https://doi.org/10.1172/jci19159 .
doi: 10.1172/jci19159
Richards, S, Aziz, N, Bale, S, Bick, D, Das, S, Gastier-Foster, J, et al.. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of medical genetics and genomics and the association for molecular Pathology. Genet Med 2015;17:405–24. https://doi.org/10.1038/gim.2015.30 .
doi: 10.1038/gim.2015.30
Rentzsch, P, Witten, D, Cooper, GM, Shendure, J, Kircher, M. CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res 2019;47:D886–94. https://doi.org/10.1093/nar/gky1016 .
doi: 10.1093/nar/gky1016
Cavaco, BM, Tomaz, RA, Fonseca, F, Mascarenhas, MR, Leite, V, Sobrinho, LG. Clinical and genetic characterization of Portuguese patients with pseudohypoparathyroidism type Ib. Endocrine 2010;37:408–14. https://doi.org/10.1007/s12020-010-9321-9 .
doi: 10.1007/s12020-010-9321-9
Turan, S, Ignatius, J, Moilanen, JS, Kuismin, O, Stewart, H, Mann, NP, et al.. De Novo STX16 deletions: an Infrequent cause of pseudohypoparathyroidism type Ib that should Be excluded in sporadic cases. J Clin Endocrinol Metab 2012;97:E2314–19. https://doi.org/10.1210/jc.2012-2920 .
doi: 10.1210/jc.2012-2920
Hanna, P, Grybek, V, Perez de Nanclares, G, Tran, LC, de Sanctis, L, Elli, F, et al.. Genetic and epigenetic defects at the GNAS locus lead to distinct patterns of skeletal growth but similar early-onset obesity. J Bone Min Res 2018;33:1480–8. https://doi.org/10.1002/jbmr.3450 .
doi: 10.1002/jbmr.3450
Mendes de Oliveira, E, Keogh, JM, Talbot, F, Henning, E, Ahmed, R, Perdikari, A, et al.. Obesity-associated GNAS mutations and the melanocortin pathway. N Engl J Med 2021;385:1581–92. https://doi.org/10.1056/nejmoa2103329 .
doi: 10.1056/nejmoa2103329
Carel, JC, Le Stunff, C, Condamine, L, Mallet, E, Chaussain, JL, Adnot, P, et al.. Resistance to the lipolytic action of epinephrine: a new feature of protein Gs deficiency. J Clin Endocrinol Metab 1999;84:4127–31. https://doi.org/10.1210/jcem.84.11.6145 .
doi: 10.1210/jcem.84.11.6145
Baldini, G, Phelan, KD. The melanocortin pathway and control of appetite-progress and therapeutic implications. J Endocrinol 2019;241:R1–33. https://doi.org/10.1530/joe-18-0596 .
doi: 10.1530/joe-18-0596
Kiuchi, Z, Reyes, M, Jüppner, H. Preferential maternal transmission of STX16-GNAS mutations responsible for autosomal dominant pseudohypoparathyroidism type Ib (PHP1B): another example of transmission ratio distortion. J Bone Min Res 2021;36:696–703. https://doi.org/10.1002/jbmr.4221 .
doi: 10.1002/jbmr.4221

Auteurs

John Odom (J)

Department of Molecular and Human Genetics, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA.

Carlos A Bacino (CA)

Department of Molecular and Human Genetics, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA.

Lefkothea P Karaviti (LP)

Department of Pediatrics, Division of Pediatric Diabetes and Endocrinology, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA.

Weimin Bi (W)

Department of Molecular and Human Genetics, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA.
Baylor Genetics, Houston, TX, USA.

Alfonso Hoyos-Martinez (A)

Department of Pediatrics, Division of Pediatric Diabetes and Endocrinology, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA.

Classifications MeSH